Vitamin D does not reduce cancer or cardiovascular events in healthy adults, trial finds
BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4776 (Published 12 November 2018) Cite this as: BMJ 2018;363:k4776- Susan Mayor
- London
High dose vitamin D supplementation does not reduce invasive cancer or cardiovascular events in healthy people over 50, a large randomised trial has found.1 Further results showed no benefits from omega 3 fatty acids in primary prevention.2
Supplemental vitamin D is currently used to prevent and treat bone related disorders, but interest has been growing in its use for preventing cancer and cardiovascular disease. This is mainly based on studies showing lower death rates from cancer and cardiovascular disease in regions with greater sun exposure, which is assumed to increase …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £138 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£23 / $37 / €30 (inc. VAT)
You can download a PDF version for your personal record.